Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Authors: Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha, Camillo Porta, Masatoshi Eto et al.

Year: 2021

LenvatinibPembrolizumabEverolimusSunitinibRenal cell carcinoma

1,696
Citations
2021
Published
10
Authors
Read PDFDOI